Lymphokine-activated killer lymphocytes: extramural clinical trials.
Sniecinski
I J
IJ
City of Hope National Medical Center, Duarte, California.
D002469:Cell Separation / Q000379:methods; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2